UB Paderborn / Katalog / Suche / in CDI

Significance of Lymph Node Sampling in Epithelial Carcinoma of the Ovary

Gynecologic oncology, 1997-06, Vol.65 (3), p.467-472

1997

Volltextzugriff (PDF)

Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer

Journal of clinical oncology, 1996-12, Vol.14 (12), p.3112-3120

1996

Volltextzugriff (PDF)

Multicenter randomized phase III trial of Epirubicin plus Paclitaxel vs Epirubicin followed by Paclitaxel in metastatic breast cancer patients: focus on cardiac safety

British journal of cancer, 2004-07, Vol.91 (1), p.45-49

2004

Volltextzugriff (PDF)

High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest

Journal of clinical oncology, 1996-02, Vol.14 (2), p.351-356

1996

Volltextzugriff (PDF)

First-line chemotherapy with epidoxorubicin, paclitaxel, and carboplatin for the treatment of advanced epithelial ovarian cancer patients

Gynecologic oncology, 2003-06, Vol.89 (3), p.354-359

2003

Volltextzugriff (PDF)

Kinetics of human hemopoietic cells after in vivo administration of granulocyte-macrophage colony-stimulating factor

The Journal of clinical investigation, 1989-02, Vol.83 (2), p.551-557

1989

Volltextzugriff (PDF)

Critical observations on BSE control in Italy

Veterinary research communications, 2003-09, Vol.27 Suppl 1, p.53-55

2003

Volltextzugriff (PDF)

Concomitant versus sequential administration of epirubicin and paclitaxel as first-line therapy in metastatic breast carcinoma: Results from the Gruppo Oncologico Nord Ovest Randomized Trial

Cancer, 2004-08, Vol.101 (4), p.704-712

2004

Volltextzugriff (PDF)

Intraperitoneal versus Intravenous Cisplatin in Combination with Intravenous Cyclophosphamide and Epidoxorubicin in Optimally Cytoreduced Advanced Epithelial Ovarian Cancer: A Randomized Trial of the Gruppo Oncologico Nord-Ovest

Gynecologic oncology, 2000-02, Vol.76 (2), p.157-162

2000

Volltextzugriff (PDF)

Intraperitoneal Carboplatin with or without Interferon-α in Advanced Ovarian Cancer Patients with Minimal Residual Disease at Second Look: A Prospective Randomized Trial of 111 Patients

Gynecologic oncology, 1997-06, Vol.65 (3), p.499-505

1997

Volltextzugriff (PDF)

Carboplatin, doxorubicin, and cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide: a randomized trial in stage III-IV epithelial ovarian carcinoma

Journal of clinical oncology, 1991-04, Vol.9 (4), p.658-663

1991

Volltextzugriff (PDF)

High-risk early-stage ovarian cancer : randomized clinical trial comparing cisplatin plus cyclophosphamide versus whole abdominal radiotherapy

American journal of clinical oncology, 1994-02, Vol.17 (1), p.72-76

1994

Volltextzugriff (PDF)

Chemotherapy with or without estrogenic recruitment in metastatic breast cancer. A randomized trial of the Gruppo Oncologico Nord Ovest (GONO)

Annals of oncology, 1996-07, Vol.7 (5), p.487-490

1996

Volltextzugriff (PDF)

Twelve‐year follow‐up of a randomized trial comparing cisplatin and cyclophosphamide with cisplatin, doxorubicin and cyclophosphamide in patients with advanced epithelial ovarian cancer

International journal of gynecological cancer, 1996-07, Vol.6 (4), p.286-290

1996

Volltextzugriff (PDF)

Intraperitoneal infusion of recombinant human tumor necrosis factor and mitoxantrone in neoplastic ascites: a feasibility study

Anticancer research, 1995-09, Vol.15 (5B), p.2207

1995

Volltextzugriff (PDF)

Accelerated-Intensified Cyclophosphamide, Epirubicin, and Fluorouracil (CEF) Compared With Standard CEF in Metastatic Breast Cancer Patients: Results of a Multicenter, Randomized Phase III Study of the Italian Gruppo Oncologico Nord-Ouest–Mammella Inter Gruppo Group

Journal of clinical oncology, 2001-04, Vol.19 (8), p.2213-2221

2001

Volltextzugriff (PDF)

Twelve-year follow-up of a randomized trial comparing cisplatin and cyclophosphamide with cisplatin, doxorubicin and cyclophosphamide in patients with advanced epithelial ovarian cancer

International journal of gynecological cancer, 1996-07, Vol.6 (4), p.286-290

1996

Volltextzugriff (PDF)

The treatment of progressive ovarian carcinoma with D-Trp-LHRH (decapeptyl)

European journal of cancer (1990), 1994, Vol.30 (12), p.1903-1904

1994

Volltextzugriff (PDF)

Primary Chemotherapy with Epirubicin and Vinorelbine in Women with Locally Advanced Breast Cancer

Anticancer research, 2005-03, Vol.25 (2B), p.1343-1348

2005

Volltextzugriff (PDF)

Antiemetic efficacy of granisetron in patients with gynecological malignancies

Anti-cancer drugs, 1997-03, Vol.8 (3), p.225-230

1997

Volltextzugriff (PDF)

Chemotherapy with estrogenic recruitment and surgery in locally advanced breast cancer: Clinical and cytokinetic results

International journal of cancer, 1987-10, Vol.40 (4), p.490-494

1987

Volltextzugriff (PDF)

Advanced ovarian cancer in the elderly: results of consecutive trials with cisplatin-based chemotherapy

Critical Reviews in Oncology and Hematology, 2001, Vol.37 (1), p.27-34

2001

Volltextzugriff (PDF)

The role of induction chemotherapy in inoperable ovarian cancer

Tumori, 1989-12, Vol.75 (6), p.609

1989

Volltextzugriff (PDF)

Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients

Breast cancer research and treatment, 2000, Vol.59 (2), p.133-139

2000

Volltextzugriff (PDF)

Epirubicin (E) plus paclitaxel (P) vs epirubicin followed by paclitaxel in metastatic breast cancer (MBC): An ongoing pharmacoeconomic study

European journal of cancer (1990), 1998-09, Vol.34, p.S90-S90

1998

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Significance of Lymph Node Sampling in Epithelial Carcinoma of the Ovary

Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer

Multicenter randomized phase III trial of Epirubicin plus Paclitaxel vs Epirubicin followed by Paclitaxel in metastatic breast cancer patients: focus on cardiac safety

High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest

First-line chemotherapy with epidoxorubicin, paclitaxel, and carboplatin for the treatment of advanced epithelial ovarian cancer patients

Kinetics of human hemopoietic cells after in vivo administration of granulocyte-macrophage colony-stimulating factor

Critical observations on BSE control in Italy

Concomitant versus sequential administration of epirubicin and paclitaxel as first-line therapy in metastatic breast carcinoma: Results from the Gruppo Oncologico Nord Ovest Randomized Trial

Intraperitoneal versus Intravenous Cisplatin in Combination with Intravenous Cyclophosphamide and Epidoxorubicin in Optimally Cytoreduced Advanced Epithelial Ovarian Cancer: A Randomized Trial of the Gruppo Oncologico Nord-Ovest

Intraperitoneal Carboplatin with or without Interferon-α in Advanced Ovarian Cancer Patients with Minimal Residual Disease at Second Look: A Prospective Randomized Trial of 111 Patients

Carboplatin, doxorubicin, and cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide: a randomized trial in stage III-IV epithelial ovarian carcinoma

High-risk early-stage ovarian cancer : randomized clinical trial comparing cisplatin plus cyclophosphamide versus whole abdominal radiotherapy

Chemotherapy with or without estrogenic recruitment in metastatic breast cancer. A randomized trial of the Gruppo Oncologico Nord Ovest (GONO)

Twelve‐year follow‐up of a randomized trial comparing cisplatin and cyclophosphamide with cisplatin, doxorubicin and cyclophosphamide in patients with advanced epithelial ovarian cancer

Intraperitoneal infusion of recombinant human tumor necrosis factor and mitoxantrone in neoplastic ascites: a feasibility study

Accelerated-Intensified Cyclophosphamide, Epirubicin, and Fluorouracil (CEF) Compared With Standard CEF in Metastatic Breast Cancer Patients: Results of a Multicenter, Randomized Phase III Study of the Italian Gruppo Oncologico Nord-Ouest–Mammella Inter Gruppo Group

Twelve-year follow-up of a randomized trial comparing cisplatin and cyclophosphamide with cisplatin, doxorubicin and cyclophosphamide in patients with advanced epithelial ovarian cancer

The treatment of progressive ovarian carcinoma with D-Trp-LHRH (decapeptyl)

Primary Chemotherapy with Epirubicin and Vinorelbine in Women with Locally Advanced Breast Cancer

Antiemetic efficacy of granisetron in patients with gynecological malignancies

Chemotherapy with estrogenic recruitment and surgery in locally advanced breast cancer: Clinical and cytokinetic results

Advanced ovarian cancer in the elderly: results of consecutive trials with cisplatin-based chemotherapy

The role of induction chemotherapy in inoperable ovarian cancer

Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients

Epirubicin (E) plus paclitaxel (P) vs epirubicin followed by paclitaxel in metastatic breast cancer (MBC): An ongoing pharmacoeconomic study

Suchergebnisse filtern